Portal de investigación
Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Chaparro, M
- Garre, A
- Alfaro, I
- Mesonero, P
- Mendoza, IV
- Rodriguez, A
- Miquel-Cusachs, J
- Riestra, S
- Navarro, P
- Parga, LD
- Gonzalez-Munoza, C
- Rivero, M
- Manosa, M
- Salazar, LF
- Jimenez, N
- Guardiola, J
- Cabriada, J
- Casbas, AG
- Sicilia, B
- Calle, JLP
- Piqueras, M
- Algaba, A
- Roncero, O
- Bargallo, A
- Sainz, E
- Barrio, J
- Calvet, X
- Garcia, A
- Barrio, ML
- Poyatos, RL
- Almela, P
- Madrigal, R
- Villarin, AJL
- Pajares, R
- Van Domselaar, M
- Gil, JL
- Gisbert, JP
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Chaparro,M,Garre,A,Alfaro,I,Iborra,M,Mesonero,P,Mendoza,IV,Rodriguez,A et al. Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry. GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND:OXFORD UNIV PRESS. 2018 p.p. 305-306.